Frontlight ResearchEarly access
Trial site
University of Michigan Cancer Center
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Head and neck cancer2 trials
- Myeloproliferative neoplasms1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Sarcoma1 trial
- Thyroid cancer1 trial
- Phase
- Phase 25 trials
- Phase 1/21 trial
- Phase 31 trial
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- University of Michigan Rogel Cancer Center3 trials
- Fred Hutchinson Cancer Center1 trial
- Incyte Biosciences International Sàrl1 trial
- Incyte Corporation1 trial
- Memorial Sloan Kettering Cancer Center1 trial
- and 2 more
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Sarcoma1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
Withdrawn
A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026